The population-based prescription database IADB.nl: Its development, usefulness in outcomes research and challenges

Expert Review of Pharmacoeconomics and Outcomes Research

Volumn 13, Issue 3, 2013, Pages 285-292

  Visser, Sipke T ^a   Schuiling Veninga, Catharina Cm ^a   Bos, Jens Hj ^a   De Jong Van Den Berg, Lolkje Tw ^a   Postma, Maarten J ^a,b  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

drug utilization; outcomes research; pharmacoeconomics; pharmacoepidemiology; pharmacy research database

Indexed keywords

AGE; DRUG DATABASE; DRUG UTILIZATION; INFORMATION PROCESSING; MEDICAL INFORMATION; NETHERLANDS; OUTCOMES RESEARCH; PHARMACY; PRESCRIPTION; PREVALENCE; REVIEW;

AGE DISTRIBUTION; DATABASES, FACTUAL; ECONOMICS, PHARMACEUTICAL; FEMALE; HUMANS; MALE; NETHERLANDS; OUTCOME ASSESSMENT (HEALTH CARE); PHARMACOEPIDEMIOLOGY; PRESCRIPTION DRUGS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TIME FACTORS;

EID: 84883528119     PISSN: 14737167     EISSN: 17448379     Source Type: Journal    
DOI: 10.1586/erp.13.20     Document Type: Review

References (18)

1. Vandenbroucke JP. Observational research, randomised trials, and two views of medical science. PLoS Med. 5(3), e67 (2008)
2. Boersma C, Klok RM, Bos JM et al. Drug costs developments after patent expiry of enalapril, fluoxetine and ranitidine: a study conducted for The Netherlands. Appl. Health Econ. Health Policy 4(3), 191-196 (2005)
3. Boersma C, Gansevoort RT, PechliVanoglou P et al.; Prevention of Renal and Vascular End Stage Disease Study Group. Screen-and-treat strategies for albuminuria to prevent cardiovascular and renal disease: cost-effectiveness of nationwide and targeted interventions based on analysis of cohort data from The Netherlands. Clin. Ther. 32(6), 1103-1121 (2010)
4. de Jong J, Van den Berg PB, de Vries TW et al. Antibiotic drug use of children in The Netherlands from 1999 till 2005. Eur. J. Clin. Pharmacol. 64, 913-919 (2008)
5. Van de Vrie-Hoekstra NW, de Vries TW, Van den Berg PB et al. Antiepileptic drug utilization in children from 1997-2005-a study from The Netherlands. Eur. J. Clin. Pharmacol. 64, 1013-1020 (2008)
6. Nijenhuis CM, Ter Horst PG, Van Rein N et al. Disturbed development of the enteric nervous system after in utero exposure of selective serotonin reuptake inhibitors and tricyclic antidepressants: part testing the hypotheses. Br. J. Clin. Pharmacol. 73(1), 126-134 (2012)
7. Bakker MK, Jentink J, Vroom F, Van Den Berg PB, De Walle HE, De Jong-Van Den Berg LT. Drug prescription patterns before, during and after pregnancy for chronic, occasional and pregnancy-related drugs in The Netherlands. BJOG 113(5), 559-568 (2006)
8. Schirm E, Tobi H, De Jong-Van Den Berg LT. Identifying parents in pharmacy data: a tool for the continuous monitoring of drug exposure to unborn children. J. Clin. Epidemiol. 57(7), 737-741 (2004)
9. Pinto-Sietsma SJ, Janssen WM, Hillege HL, Navis G, De Zeeuw D, De Jong PE. Urinary albumin excretion is associated with renal functional abnormalities in a nondiabetic population. J. Am. Soc. Nephrol. 11(10), 1882-1888 (2000)
10. Atthobari J, Brantsma AH, Gansevoort RT et al.; PREVEND study group. The effect of statins on urinary albumin excretion and glomerular filtration rate: results from both a randomized clinical trial and an observational cohort study. Nephrol. Dial. Transplant. 21(11), 3106-3114 (2006)
11. Boersma C, Postma MJ, Visser ST et al.; PREVEND Study Group. Baseline albuminuria predicts the efficacy of blood pressure-lowering drugs in preventing cardiovascular events. Br. J. Clin. Pharmacol. 65(5), 723-732 (2008)
12. Joosten H, Izaks GJ, Slaets JP et al. Association of cognitive function with albuminuria and eGFR in the general population. Clin. J. Am. Soc. Nephrol. 6(6), 1400-1409 (2011)
13. PechliVanoglou P, Van der Veen WJ, Bos JH, Postma MJ. Analyzing generic and branded substitution patterns in The Netherlands using prescription data. BMC Health Serv. Res. 11, 89 (2011)
14. Buurma H, Beudeker HJ, de Jong-Van den Berg LTW et al. Het Geneesmiddel (5th Edition). Elsevier Gezondheidszorg, Maarssen, The Netherlands (2009)
15. Kildemoes HW, Sørensen HT, Hallas J. The Danish National Prescription Registry. Scand. J. Public Health 39(Suppl. 7), 38-41 (2011)
16. Klein JP, Moeschberger ML. Censoring and truncation. In: Survival Analysis: Techniques for Censored and Truncated Data. Springer, Berlin, Germany (2003)
17. Vegter S, Nguyen NH, Visser ST, de Jong-Van den Berg LT, Postma MJ, Boersma C. Compliance, persistence, and switching patterns for ACE inhibitors and ARBs. Am. J. Manag. Care 17(9), 609-616 (2011)
18. Stolk RP, Rosmalen JG, Postma DS et al. Universal risk factors for multifactorial diseases: LifeLines: a three-generation population-based study. Eur. J. Epidemiol. 23(1), 67-74 (2008)